# NEOSPLICE THERAPEUTICS, INC.: Isoform?Resolved Target Discovery and Validation in Cancer

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | NEOSPLICE THERAPEUTICS, INC. |
| Location | NEW YORK, NY |
| Project | Isoform?Resolved Target Discovery and Validation in Cancer |
| Project number | 1R43CA314782-01 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $406,500 |
| Awarded | 2026-09-09 |
| Project period | 2026-09-09 to 2027-08-31 |
| UEI | ZJHHBAXNB7B8 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409904). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.